Taking peoplePhase 1
Intra-articular Allocetra in Osteoarthritis of the of the Temporomandibular Joint (TMJ)
Key facts
- Who runs it
- Dr. Amit Druyan
- Where
- Israel1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 6 people, planned
- Started
- 15 Dec 2024
- Planned end
- 8 Apr 2026
- Type of study
- Interventional
- Treatments tested
- Allocetra
- Record updated
- 27 December 2024
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Diagnosed with temporomandibular OA in the target TMJ
- Inflammatory findings by Magnetic Resonance Imaging (MRI)
- Acceptable blood workup results (CBC, electrolytes, kidney and liver function)
Who cannot take part
- Prior intra-articular injection to the target TMJ within 3 months prior to treatment
- Any significant injury or surgery to the target TMJ
- Evidence of active local infection in the vicinity of the target TMJ or clinically significant active infection anywhere in the body
- Patients with a known neurological disease or rheumatic condition, a major medical condition that would affect quality of life and influence the results of the study, or other pain of unknown etiology
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is a single center trial to assess the safety and initial efficacy of intra-articular administration of Allocetra to patients with Temporomandibular Joint Osteoarthritis (TMJ-OA)
The group in the trial
- Intra-articular Injection of Allocetra performed once on Day 1 of the studyTreatment being tested
Treatment: Allocetra
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of Allocetra by Intra-articular Injection for the Treatment of Temporomandibular Joint Osteoarthritis (TMJ-OA)
- Fit questions
- Built from NCT06748651, who can take part
- Record updated
- 27 December 2024